Everything happening across the MedTech Innovator ecosystem
Company announcements, alumni milestones, patient stories, and perspective from the MTI team — jump to what you're looking for.
Company News
Milestones, partnerships and announcements from across MedTech Innovator.
MedTech Innovator Welcomes Dr. Jeffrey Shuren as Advisor
Dr. Jeffrey Shuren, former Director of the FDA's Center for Devices and Radiological Health, joins MedTech Innovator as an Advisor to guide portfolio companies on regulatory strategy and market access.
Zonova Wins 2026 Vision Award at Wilson Sonsini's Digital Health Conference
Zonova, which aims to make infection-resistant medical devices the new standard of care, won the 2026 Vision Award by live audience vote at Wilson Sonsini's 33rd Annual Medical Device Digital Health Conference.
:format(webp))
MedTech Innovator Unveils 65 Startups in its 2026 Accelerator Cohort and Launches the MTI Index, the Definitive Recognition Platform for MedTech Innovation
MedTech Innovator announced the 65 companies in its 2026 Accelerator Cohort — the top 4% of 1,835 global applicants — and launched the MTI Index, a recognition platform that makes the MTI portfolio discoverable by investors, health systems, and media.
Alumni News
Where our program graduates are making an impact.
:format(webp))
Samay named to the 2026 Colombia Early Stage 100 by NuMundo Ventures
Samay is developing Sylvee, an AI-powered wearable designed to detect COPD before spirometry can, enabling earlier and more accessible respiratory disease detection for the millions of people who need it.
:format(webp))
First-in-Human Trial of NeoCast, Arsenal Medical's Liquid Embolic Biomaterial
NeoCast is a solvent-free, non-adhesive biomaterial engineered to achieve microvascular occlusion. EMBO-01 is the first-in-human trial of NeoCast for the pre-surgical embolization of hypervascular brain tumors.
:format(webp))
Hamilton company acquires Charlottesville-based UVA spin-off company Cerillo
Hamilton Company, a global life sciences and laboratory technology company, has acquired Charlottesville-based, University of Virginia spin-off company Cerillo.
Patient Stories
First-hand accounts from the people our technology was built for.
:format(webp))
A Patient Had a Brain Aneurysm That Wouldn’t Respond to Treatment. MonarchBio’s New Device Changed Everything.
A 74-year-old woman's giant brain aneurysm kept growing despite treatment with the gold-standard flow diverter. A rescue procedure with MonarchBio's Titan stent sealed it within four weeks, and her symptoms fully resolved.
:format(webp))
When data becomes care: Amy’s pregnancy journey with RenewRx
Managing diabetes through a high-risk pregnancy left Amy with scattered data and slow feedback. RenewRx turned her real-time numbers into clear, actionable care, keeping her glucose in range more than 50% better with less insulin.
:format(webp))
From Concept to Clinic: ResQFoam™ Marks a First-in-Human Milestone in Trauma Care
In the REVIVE trial, Arsenal Medical's ResQFoam was used in a human patient for the first time, stabilizing a 34-year-old man in hemorrhagic shock long enough to reach surgery. He survived.
MedTech Innovator Blog
Perspective from the MTI team on where medtech is heading.
:format(webp))
2026 Innovator Summit: Bridging Innovators, Shaping the Future
The 2026 Innovator Summit, held June 2–4 in San Francisco, brought together the MTI, BioTools Innovator, MedTech Innovator Asia Pacific, and U.S. Market Access Program cohorts with partners, mentors, judges, and alumni for three days of learning and connection.
:format(webp))
The 2026 MTI Index
The inaugural 2026 MTI Index tracks 65 MTI Index Companies, the top 3.6% of more than 1,800 global applicants, as a live, scored class starting at 1,000 points on June 1, 2026.
:format(webp))
The 2026 Radar Forum Recap: Our Biggest Event Yet
More than 140 early-stage medtech companies pitched in person at the 2026 Radar Forum in Manhattan Beach, evaluated by investors, regulators, clinicians, payers, and strategics. Here's what stood out and why it matters.